Alkeran Powder For Solution For Injection 50Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Alkeran: Powder for solution for injection (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MELPHALAN (MEL fa lan) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat multiple myeloma.

In-Depth Information
Select a Medication

Alkeran 50mg Powder for Injection

NDC: 001730130
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Myeloma, Stem Cell Transplant Preparation

Sometimes used for but not FDA approved for the following conditions:
Amyloidosis

Alkeran 50mg Powder for Injection

Reported Side Effects for Alkeran 50mg Powder for Injection

Intestinal Bleeding Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
<64.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
<28.0%*
Severity: MILD
Onset: EARLY
Mouth Sores Incidence:
<10.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Decreased Appetite Incidence:
<49.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
<48.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<3.0%*
Severity: SEVERE
Onset: EARLY
Upset Stomach Incidence:
<26.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<28.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Failure Incidence:
>1.6%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Anaphylactoid Reactions Incidence:
2.0-22.4%*
Severity: SEVERE
Onset: RAPID
Secondary Malignancy Incidence:
2.0-19.5%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
No Menstrual Periods Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Low Potassium Levels Incidence:
28.0%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
33.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
38.0%*
Severity: MILD
Onset: EARLY
Low Phosphate Level Incidence:
48.0%*
Severity: SEVERE
Onset: DELAYED
Low Lymphocytes Incidence:
>50.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
>50.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
>50.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
>50.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Alkeran

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5